Masanori Asakura

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy

Masanori Asakura, Masafumi Kitakaze, Seiji Takashima et al. · Nature Medicine · 2002 · 718 citations

Adam12 Processing, Cardiac Muscle, Cardiomyopathy +9

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

Masafumi Kitakaze, Masanori Asakura, Jiyoong Kim et al. · The Lancet · 2007 · 469 citations

Thrombosis, Cardiovascular Disease, Cardiovascular Pharmacology +4

Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study

Masanori Asakura, Yasunori Ueda, Osamu Yamaguchi et al. · Journal of the American College of Cardiology · 2001 · 382 citations

Radiology, Cardiovascular Disease, Extensive Development +11

Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis

Seiji Takashima, Masafumi Kitakaze, Masanori Asakura et al. · Proceedings of the National Academy of Sciences · 2002 · 368 citations · Full text

Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function

Ryo Iwamoto, Satoru Yamazaki, Masanori Asakura et al. · Proceedings of the National Academy of Sciences · 2003 · 340 citations · Full text